PEG & ADCs
- Next-Generation ADC Bispecific & Multi-Payload Trends
- What Are ADC Linkers: Cleavable vs. Non-Cleavable Linkers
- 23 Antibody-drug Conjugates (ADCs) Approved Globally
- FDA Approved Antibody-Drug Conjugates (ADCs) By 2026
- ADC Advances in 2026: New Approvals and Emerging Breakthroughs
- First Bispecific ADC Approved Globally: More Bispecific ADCs in Clinical Trials
- ADCs in Autoimmune Diseases: Expanding ADC Technology Beyond Oncology
- Nectin-4 ADCs at ASCO 2026: Pipeline and Clinical Updates
- Global Sales of Antibody-drug Conjugates (ADCs) in 2025
- From ADC to XDC: Types of Novel Drug Conjugates
